Lessons learnt from assembling screening libraries for drug discovery for neglected diseases

ChemMedChem

Volumn 3, Issue 3, 2008, Pages 435-444

  Brenk, Ruth ^a   Schipani, Alessandro ^a   James, Daniel ^a   Krasowski, Agata ^a   Gilbert, Ian Hugh ^a   Frearson, Julie ^a   Wyatt, Paul Graham ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Compound selection; High throughput screening; Kinase inhibitors; Neglected diseases; Virtual screening

Indexed keywords

DRUG; PEPTIDE LIBRARY; PROTEIN KINASE INHIBITOR;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; FACTUAL DATABASE; METHODOLOGY; STRUCTURE ACTIVITY RELATION;

CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; DRUG DESIGN; PEPTIDE LIBRARY; PHARMACEUTICAL PREPARATIONS; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 48049086591     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200700139     Document Type: Article

References (47)

1. P. Herrling, Nature 2007, 449, 174-175.
2. R. Pink, A. Hudson, M. A. Mouries, M. Bendig, Nat. Rev. Drug Discovery 2005, 4, 727-740.
3. M. Wastfelt, B. Fadeel, J. I. Henter, J. Intern. Med. 2006, 260, 1-10.
4. P. Trouiller, P. Olliaro, E. Torreele, J. Orbinski, R. Laing, N. Ford, Lancet 2002, 359, 2188-2194.
5. M. E. Haffner, J. Whitley, M. Moses, Nat. Rev. Drug Discovery 2002, 1, 821-825.
6. S. Nwaka, A. Hudson, Nat. Rev. Drug Discovery 2006, 5, 941-955.
7. J. Bajorath, Nat. Rev. Drug Discovery 2002, 1, 882-894.
8. K. H. Bleicher, H. J. Bohm, K. Muller, A. I. Alanine, Nat. Rev. Drug Discovery 2003, 2, 369-378.
9. H. Eckert, J. Bajorath, Drug Discovery Today 2007, 12, 225-233.
10. G. Klebe, Drug Discovery Today 2006, 11, 580-594.
11. P. J. Hajduk, J. Greer, Nat. Rev. Drug Discovery 2007, 6, 211-219.
12. W. P. Walters, M. Namchuk, Nat. Rev. Drug Discovery 2003, 2, 259-266.
13. J. L. Miller, Curr. Top. Med. Chem. 2006, 6, 19-29.
14. R. Lahana, Drug Discovery Today 1999, 4, 447-448.
15. S. J. Teague, A. M. Davis, P. D. Leeson, T. Oprea, Angew. Chem. 1999, 111, 3962-3967;
16. Angew. Chem. Int. Ed. 1999, 38, 3743-3748.
17. C. Rossi, D. Padmanaban, J. Ni, L. A. Yeh, M. A. Glicksman, H. Waldner, J. Biomol. Screening 2007, 12, 481-489.
18. S. L. Johnson, L. H. Chen, M. Pellecchia, Bioorg. Chem. 2007, 35, 306-312.
19. D. C. Martyn, D. C. Jones, A. H. Fairlamb, J. Clardy, Bioorg. Med. Chem. Lett. 2007, 17, 1280-1283.
20. G. A. Holloway, J. B. Baell, A. H. Fairlamb, P. M. Novello, J. P. Parisot, J. Richardson, K. G. Watson, I. P. Street, Bioorg. Med. Chem. Lett. 2007, 17, 1422-1427.
21. A. R. Renslo, J. H. McKerrow, Nat. Chem. Biol. 2006, 2, 701-710.
22. W. N. Hunter, M. S. Alphey, C. S. Bond, A. W. Schuttelkopf, Biochem. Soc. Trans. 2003, 31, 607-610.
23. C. Naula, M. Parsons, J. C. Mottram, Biochim. Biophys. Acta Proteins Proteomics 2005, 1754, 151-159.
24. P. Cohen, Nat. Rev. Drug Discovery 2002, 1, 309-315.
25. I. Kola, J. Landis, Nat. Rev. Drug Discovery 2004, 3, 711-715.
26. T. I. Oprea, A. M. Davis, S. J. Teague, P. D. Leeson, J. Chem. Inf. Comput. Sci. 2001, 41, 1308-1315.
27. M. M. Hann, A. R. Leach, G. Harper, J. Chem. Inf. Comput. Sci. 2001, 41, 856-864.
28. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3-25.
29. M. Hann, B. Hudson, X. Lewell, R. Lifely, L. Miller, N. Ramsden, J. Chem. Inf. Comput. Sci. 1999, 39, 897-902.
30. N. Baurin, R. Baker, C. Richardson, I. Chen, N. Foloppe, A. Potter, A. Jordan, S. Roughley, M. Parratt, P. Greaney, D. Morley, R. E. Hubbard, J. Chem. Inf. Comput. Sci. 2004, 44, 643-651.
31. J. J. Liao, J. Med. Chem. 2007, 50, 409-424.
32. R. Nilakantan, F. Immermann, K. Haraki, Comb. Chem. High Throughput Screening 2002, 5, 105-110.
33. J. Xu, J. Med. Chem. 2002, 45, 5311-5320.
34. D. J. Payne, M. N. Gwynn, D. J. Holmes, D. L. Pompliano, Nat. Rev. Drug Discovery 2007, 6, 29-40.
35. M. M. Hann, T. I. Oprea, Curr. Opin. Chem. Biol. 2004, 8, 255-263.
36. R. S. Bohacek, C. McMartin, W. C. Guida, Med. Res. Rev. 1996, 16, 3-50.
37. T. Fink, H. Bruggesser, J. Reymond, Angew. Chem. 2005, 117, 1528-1532;
38. Angew. Chem. Int. Ed. 2005, 44, 1504-1508.
39. T. I. Oprea, J. Comput.-Aided Mol. Des. 2000, 14, 251-264.
40. M. Congreve, R. Carr, C. Murray, H. Jhoti, Drug DiscoveryT oday 2003, 8, 876-877.
41. G. M. Makara, J. Med. Chem. 2007, 50, 3214-3221.
42. K. V. Balakin, N. P. Savchuk, I. V. Tetko, Curr. Med. Chem. 2006, 13, 223-241.
43. B. C. Pearce, M. J. Sofia, A. C. Good, D. M. Drexler, D. A. Stock, J. Chem. Inf. Model. 2006, 46, 1060-1068.
44. A. Schuffenhauer, N. Brown, P. Selzer, P. Ertl, E. Jacoby, J. Chem. Inf. Model. 2006, 46, 525-535.
45. S. Muresan, J. Sadowski, J. Chem. Inf. Model. 2005, 45, 888-893.
46. R. Nilakantan, D. S. Nunn, Drug Discovery Today 2003, 8, 668-672.
47. R. Nilakantan, N. Bauman, K. S. Haraki, J. Comput.-Aided Mol. Des. 1997, 11, 447-452.